News & Analysis on Clinical Trial Services & Contract Research And Development
Cardinal Health reported a mixed bag of results in its fourth quarter, with revenues rising well on the back of rising demand for its pharmaceutical distribution services, although operating profit fell 9 per cent, in line with forecasts, dragged down...
The raft of pharmaceutical companies reporting results for the second quarter of 2005 provided mixed indications as to the state of the industry. The claim that pipeline product fruition is beginning to return among the pharmaceutical and...
Researchers have discovered that a protein, which acts as a fundamental inhibitor of cell movement or migration, may be a likely target for new drug development aimed at decreasing tumour metastasis, or spread, throughout the body.
The world's second largest pharmaceutical company, GlaxoSmithKline, is investing close to €100 million in a new manufacturing facility in Dresden, Germany, for flu vaccines.
BioFocus and Organon have announced they are to embark on the second phase of collaborative projects involving key GPCR targets for therapeutic applications and drug discovery.
Altana Chemie, the specialty chemicals unit of German pharmaceutical and chemicals company Altana, has said it plans to acquire Eckart for €630 million in cash, in what is the largest purchase in the company's history.